{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:39:10Z","timestamp":1790505550097,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1124\/jpet.102.048439","type":"journal-article","created":{"date-parts":[[2003,6,18]],"date-time":"2003-06-18T19:15:01Z","timestamp":1055963701000},"page":"195-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Risperidone Attenuates the Discriminative-Stimulus Effects of d-Amphetamine in Humans"],"prefix":"10.1016","volume":"306","author":[{"given":"Craig R.","family":"Rush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Stoops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon R.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.A.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon S.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.048439_bib1","doi-asserted-by":"crossref","unstructured":"Arnt J (1992) Sertindole and several antipsychotic drugs differentially inhibit the discriminative stimulus effects of amphetamine, LSD and St 587 in rats. Behav Pharmacol 3: 11\u201318.","DOI":"10.1097\/00008877-199203010-00004"},{"key":"10.1124\/jpet.102.048439_bib2","doi-asserted-by":"crossref","unstructured":"Arnt J (1996) Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system? Psychopharmacology (Berl) 124: 117\u2013125.","DOI":"10.1007\/BF02245611"},{"key":"10.1124\/jpet.102.048439_bib3","doi-asserted-by":"crossref","unstructured":"Bickel WK, Oliveto AH, Kamien JB, Higgins ST, and Hughes JR (1993) A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. J Pharmacol Exp Ther 264: 360\u2013367.","DOI":"10.1016\/S0022-3565(25)10277-2"},{"key":"10.1124\/jpet.102.048439_bib4","doi-asserted-by":"crossref","unstructured":"Chait LD and Johanson CE (1988) Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers. Psychopharmacology (Berl) 96: 302\u2013308.","DOI":"10.1007\/BF00216054"},{"key":"10.1124\/jpet.102.048439_bib5","doi-asserted-by":"crossref","unstructured":"Chait LD, Uhlenhuth EH, and Johanson CE (1984) An experimental paradigm for studying the discriminative stimulus properties of drugs in humans. Psychopharmacology (Berl) 82: 272\u2013274.","DOI":"10.1007\/BF00427789"},{"key":"10.1124\/jpet.102.048439_bib6","doi-asserted-by":"crossref","unstructured":"Chait LD, Uhlenhuth EH, and Johanson CE (1985) The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology (Berl) 86: 307\u2013312.","DOI":"10.1007\/BF00432219"},{"key":"10.1124\/jpet.102.048439_bib7","doi-asserted-by":"crossref","unstructured":"Chait LD, Uhlenhuth EH, and Johanson CE (1986a) Human drug discrimination: d-amphetamine and other anorectics. NIDA Res Monogr 67: 161\u2013167.","DOI":"10.1037\/e470132004-001"},{"key":"10.1124\/jpet.102.048439_bib8","doi-asserted-by":"crossref","unstructured":"Chait LD, Uhlenhuth EH, and Johanson CE (1986b) The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans. Pharmacol Biochem Behav 24: 1665\u20131672.","DOI":"10.1016\/0091-3057(86)90503-4"},{"key":"10.1124\/jpet.102.048439_bib9","unstructured":"Di Marino ME, Haberny KA, Felch LJ, Walsh SL, Preston KL, and Bigelow GE (1998) Development of a subjective rating scale sensitive to acute cocaine administration. National Institute on Drug Abuse Research Monograph Series, Problems of Drug Dependence, 1997: Proceedings of the 59th Annual Scientific Meeting 178: 139."},{"key":"10.1124\/jpet.102.048439_bib10","doi-asserted-by":"crossref","unstructured":"Fischman MW and Johanson CE (1998) Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers. Behav Pharmacol 9: 479\u2013498.","DOI":"10.1097\/00008877-199811000-00002"},{"key":"10.1124\/jpet.102.048439_bib11","doi-asserted-by":"crossref","unstructured":"Fitton A and Heel RC (1990) Clozapine. A review of its pharmacological properties and therapeutic use in schizophrenia. Drugs 40: 722\u2013747.","DOI":"10.2165\/00003495-199040050-00007"},{"key":"10.1124\/jpet.102.048439_bib12","doi-asserted-by":"crossref","unstructured":"Fulton B and Goa KL (1997) Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs 53: 281\u2013298.","DOI":"10.2165\/00003495-199753020-00007"},{"key":"10.1124\/jpet.102.048439_bib13","doi-asserted-by":"crossref","unstructured":"Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D, and Bailey R (2000) Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmacol 20: 305\u2013310.","DOI":"10.1097\/00004714-200006000-00003"},{"key":"10.1124\/jpet.102.048439_bib14","doi-asserted-by":"crossref","unstructured":"Grant S and Fitton A (1994) Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs 48: 253\u2013273.","DOI":"10.2165\/00003495-199448020-00009"},{"key":"10.1124\/jpet.102.048439_bib15","doi-asserted-by":"crossref","unstructured":"Gupta S, Black DW, and Smith DA (1994) Risperidone: review of its pharmacology and therapeutic use in schizophrenia. Ann Clin Psychiatry 6: 173\u2013180.","DOI":"10.3109\/10401239409149000"},{"key":"10.1124\/jpet.102.048439_bib16","doi-asserted-by":"crossref","unstructured":"Heishman SJ and Henningfield JE (1991) Discriminative stimulus effects of d-amphetamine, methylphenidate and diazepam in humans. Psychopharmacology (Berl) 103: 436\u2013442.","DOI":"10.1007\/BF02244241"},{"key":"10.1124\/jpet.102.048439_bib17","doi-asserted-by":"crossref","unstructured":"Jasinski D (1977) Assessment of the abuse potentiality of morphine-like drugs (methods used in man), in Drug Addiction I (Martin WR ed) pp 197\u2013258, Springer-Verlag New York Inc., New York.","DOI":"10.1007\/978-3-642-66612-4_4"},{"key":"10.1124\/jpet.102.048439_bib18","doi-asserted-by":"crossref","unstructured":"Kamien JB, Bickel WK, Hughes JR, Higgins ST, and Smith BJ (1993) Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology (Berl) 111: 259\u2013270.","DOI":"10.1007\/BF02244940"},{"key":"10.1124\/jpet.102.048439_bib19","unstructured":"Keegan D (1994) Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug. Can J Psychiatry 39: S46\u2013S52."},{"key":"10.1124\/jpet.102.048439_bib20","doi-asserted-by":"crossref","unstructured":"Kilbey MM and Ellinwood EH Jr (1979) Discriminative stimulus properties of psychomotor stimulants in the cat. Psychopharmacology (Berl) 63: 151\u2013153.","DOI":"10.1007\/BF00429694"},{"key":"10.1124\/jpet.102.048439_bib21","doi-asserted-by":"crossref","unstructured":"Kollins SH and Rush CR (1999) Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans. Pharmacol Biochem Behav 64: 319\u2013326.","DOI":"10.1016\/S0091-3057(99)00084-2"},{"key":"10.1124\/jpet.102.048439_bib22","doi-asserted-by":"crossref","unstructured":"Lamb RJ and Henningfield JE (1994) Human d-amphetamine drug discrimination: methamphetamine and hydromorphone. J Exp Anal Behav 61: 169\u2013180.","DOI":"10.1901\/jeab.1994.61-169"},{"key":"10.1124\/jpet.102.048439_bib23","doi-asserted-by":"crossref","unstructured":"Martin WR, Sloan JW, Sapira JD, and Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12: 245\u2013258.","DOI":"10.1002\/cpt1971122part1245"},{"key":"10.1124\/jpet.102.048439_bib24","doi-asserted-by":"crossref","unstructured":"McLeod DR, Griffiths RR, Bigelow GE, and Yingling JE (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instr 14: 463\u2013466.","DOI":"10.3758\/BF03203313"},{"key":"10.1124\/jpet.102.048439_bib25","doi-asserted-by":"crossref","unstructured":"Mechanic JA, Wasielewski JA, Carl KL, and Holloway FA (2002) Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine. Pharmacol Biochem Behav 72: 767\u2013777.","DOI":"10.1016\/S0091-3057(02)00766-9"},{"key":"10.1124\/jpet.102.048439_bib26","doi-asserted-by":"crossref","unstructured":"Meert TF (1991) Application of drug discrimination with drugs of abuse to develop new therapeutic agents. NIDA Res Monogr 307\u2013323.","DOI":"10.1037\/e496182006-019"},{"key":"10.1124\/jpet.102.048439_bib27","unstructured":"Meert TF (1996) Serotonin mechanisms in antipsychotic treatment: evidence from drug discrimination studies, in Serotonin in Antipsychotic Treatment. Mechanisms and Clinical Practice (Kane JM, Moller HJ, and Awouters F eds) pp 109\u2013130, Marcel Dekker, Inc., New York."},{"key":"10.1124\/jpet.102.048439_bib28","doi-asserted-by":"crossref","unstructured":"Nielsen EB and Jepsen SA (1985) Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs. Eur J Pharmacol 111: 167\u2013176.","DOI":"10.1016\/0014-2999(85)90753-8"},{"key":"10.1124\/jpet.102.048439_bib29","unstructured":"Oliveto AH, Bickel WK, Hughes JR, Higgins ST, and Badger G (1997) Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans. Behav Pharmacol 8: 124\u2013138."},{"key":"10.1124\/jpet.102.048439_bib30","doi-asserted-by":"crossref","unstructured":"Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, and Fenwick JW (1992) Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther 261: 885\u2013894.","DOI":"10.1016\/S0022-3565(25)11160-9"},{"key":"10.1124\/jpet.102.048439_bib31","doi-asserted-by":"crossref","unstructured":"Perkins KA, Sanders M, Fonte C, Wilson AS, White W, Stiller R, and McNamara D (1999) Effects of central and peripheral nicotinic blockade on human nicotine discrimination. Psychopharmacology (Berl) 142: 158\u2013164.","DOI":"10.1007\/s002130050875"},{"key":"10.1124\/jpet.102.048439_bib32","unstructured":"Physician\u2019s Desk Reference (2003) Medical Economics Company, Inc., Oradell, NJ."},{"key":"10.1124\/jpet.102.048439_bib33","doi-asserted-by":"crossref","unstructured":"Rush CR and Baker RW (2001) Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol 9: 59\u201373.","DOI":"10.1037\/\/1064-1297.9.1.59"},{"key":"10.1124\/jpet.102.048439_bib34","doi-asserted-by":"crossref","unstructured":"Rush CR, Kelly TH, Hays LR, and Wooten AF (2002) Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug Alcohol Depend 67: 311\u2013322.","DOI":"10.1016\/S0376-8716(02)00082-0"},{"key":"10.1124\/jpet.102.048439_bib35","doi-asserted-by":"crossref","unstructured":"Rush CR, Kollins SH, and Pazzaglia PJ (1998) Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 6: 32\u201344.","DOI":"10.1037\/\/1064-1297.6.1.32"},{"key":"10.1124\/jpet.102.048439_bib36","doi-asserted-by":"crossref","unstructured":"Wachtel S, Ortengren A, and Wit H (2002) The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend 68: 23\u201333.","DOI":"10.1016\/S0376-8716(02)00104-7"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524307876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524307876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.048439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:27:12Z","timestamp":1739975232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524307876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S0022356524307876"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.048439","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risperidone Attenuates the Discriminative-Stimulus Effects of d-Amphetamine in Humans","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.048439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}